555 related articles for article (PubMed ID: 30809310)
1. RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog.
Cao J; Zhao M; Liu J; Zhang X; Pei Y; Wang J; Yang X; Shen B; Zhang J
Theranostics; 2019; 9(3):811-828. PubMed ID: 30809310
[TBL] [Abstract][Full Text] [Related]
2. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
3. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
5. RAB27A-dependent release of exosomes by liver cancer stem cells induces Nanog expression in their differentiated progenies and confers regorafenib resistance.
Huang H; Hou J; Liu K; Liu Q; Shen L; Liu B; Lu Q; Zhang N; Che L; Li J; Jiang S; Wang B; Wen Q; Hu L; Gao J
J Gastroenterol Hepatol; 2021 Dec; 36(12):3429-3437. PubMed ID: 34258777
[TBL] [Abstract][Full Text] [Related]
6. Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma.
Jiang L; Shan J; Shen J; Wang Y; Yan P; Liu L; Zhao W; Xu Y; Zhu W; Su L; Chen J; Cheng F; Yao H; Xu H; Qian C; Liang Z
Oncotarget; 2016 Jun; 7(24):36814-36828. PubMed ID: 27167111
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcylation of RACK1 promotes hepatocellular carcinogenesis.
Duan F; Wu H; Jia D; Wu W; Ren S; Wang L; Song S; Guo X; Liu F; Ruan Y; Gu J
J Hepatol; 2018 Jun; 68(6):1191-1202. PubMed ID: 29454068
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.
Lai KP; Chen J; He M; Ching AK; Lau C; Lai PB; To KF; Wong N
Int J Cancer; 2014 Oct; 135(8):1790-9. PubMed ID: 24585547
[TBL] [Abstract][Full Text] [Related]
9. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
[TBL] [Abstract][Full Text] [Related]
10. Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma.
Ruan Y; Sun L; Hao Y; Wang L; Xu J; Zhang W; Xie J; Guo L; Zhou L; Yun X; Zhu H; Shen A; Gu J
J Clin Invest; 2012 Jul; 122(7):2554-66. PubMed ID: 22653060
[TBL] [Abstract][Full Text] [Related]
11. CD133
Liu K; Hao M; Ouyang Y; Zheng J; Chen D
Sci Rep; 2017 Jan; 7():41499. PubMed ID: 28134312
[TBL] [Abstract][Full Text] [Related]
12. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C
Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773
[TBL] [Abstract][Full Text] [Related]
13. Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog.
Ye T; Li J; Sun Z; Liu Y; Kong L; Zhou S; Tang J; Wang J; Xing HR
Cancer Med; 2019 Mar; 8(3):1232-1245. PubMed ID: 30740909
[TBL] [Abstract][Full Text] [Related]
14. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
[TBL] [Abstract][Full Text] [Related]
15. Zinc finger protein X-linked promotes expansion of EpCAM
Wang C; Fu SY; Wang MD; Yu WB; Cui QS; Wang HR; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Yang Y; Wu MC; Zhou WP
Mol Oncol; 2017 May; 11(5):455-469. PubMed ID: 28156061
[TBL] [Abstract][Full Text] [Related]
16. Insights into the
Zhang W; Sui Y; Ni J; Yang T
Int J Biol Sci; 2016; 12(11):1372-1381. PubMed ID: 27877089
[TBL] [Abstract][Full Text] [Related]
17.
Das B; Pal B; Bhuyan R; Li H; Sarma A; Gayan S; Talukdar J; Sandhya S; Bhuyan S; Gogoi G; Gouw AM; Baishya D; Gotlib JR; Kataki AC; Felsher DW
Cancer Res; 2019 Aug; 79(16):4015-4025. PubMed ID: 31266772
[TBL] [Abstract][Full Text] [Related]
18. CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance.
Xu M; Fang S; Song J; Chen M; Zhang Q; Weng Q; Fan X; Chen W; Wu X; Wu F; Tu J; Zhao Z; Ji J
Cell Death Dis; 2018 Sep; 9(10):957. PubMed ID: 30237545
[TBL] [Abstract][Full Text] [Related]
19. MEK1 signaling promotes self-renewal and tumorigenicity of liver cancer stem cells via maintaining SIRT1 protein stabilization.
Cheng J; Liu C; Liu L; Chen X; Shan J; Shen J; Zhu W; Qian C
Oncotarget; 2016 Apr; 7(15):20597-611. PubMed ID: 26967560
[TBL] [Abstract][Full Text] [Related]
20. TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma.
Lai HH; Li CW; Hong CC; Sun HY; Chiu CF; Ou DL; Chen PS
Mol Oncol; 2019 Apr; 13(4):928-945. PubMed ID: 30657254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
